PRINCETON, N.J., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the introduction of Simcyp™ Biopharmaceutics software. It is designed ...

(MENAFN- EIN Presswire) EINPresswire/ -- The global Bioequivalence Studies Market size was US$ 701.70 Million in 2024 and is expected to reach US$ 1349.06 Million by 2033, growing at a CAGR of 7.5% ...

A new guideline for conducting bioequivalence studies was adopted by the CPMP in January and it becomes fully effective as of August 2010. A new guideline 1 for conducting bioequivalence studies was ...

With the ministry of health and family welfare making bioequivalence studies compulsory for all drugs on April 3 this year, the focus on patient safety and efficacy has improved greatly. This mandate ...

FDA has been encouraging drug sponsors to use a systematic approach such as quality-by-design principles for pharmaceutical development. In the United States, drug products are deemed therapeutically ...